Skip to Content

AR (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint AR is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AR

Rabeprazole sodium delayed-release 20 mg AR
Rabeprazole sodium delayed-release 20 mg AR
Rabeprazole sodium delayed-release 20 mg AR

Rabeprazole Sodium Delayed-Release

Imprint
AR
Strength
20 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
National Drug Code (NDC)
65162-0724

Get help with Imprint Code FAQs.

Related Images for "AR"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.